基本信息
浏览量:85
职业迁徙
个人简介
Maria Tektonidou is Professor of Internal Medicine - Rheumatology, Head of Rheumatology Unit and Head of the National Center of Expertise for Rare and & Complex Connective Tissue and Musculoskeletal Diseases at the First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Greece. She is a member of the Executive board of the "Joint Academic Rheumatology program, School of Medicine, National and Kapodistrian University of Athens", EULAR Centre of Excellence. From 2009 to 2019, she has been working (1-2 monthly visits/year) as a Guest Researcher at the NIAMS/NIH, Bethesda, USA.
Dr. Tektonidou is a member of the steering committee -she was Executive Committee member for 6 years (2014-2021)- of the ‘AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) and a member of the Executive Committee of the ‘European Lupus Society-SLEuro’ (2018-present). She is leading the ‘EULAR Antiphospholipid syndrome study group” (2019-) and she is a member of the ‘European Forum on Antiphospholipid Antibodies’ and the “EULAR Systemic Lupus Erythematosus (SLE) study group”.
She was a member of the ‘Task Force on Non-criteria APS Manifestations and on Catastrophic APS’ and the Task force group for ‘Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients’. She was co-author of the ‘EULAR recommendations for the management of SLE with neuropsychiatric manifestations’, the ‘Joint EULAR/ERA-EDTA recommendations for the management of adult and paediatric lupus nephritis’, the ‘EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with SLE and/or APS’ and the “2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus”. She is Steering committee member of the task force for the development of the New “ACR/EULAR Classification Criteria for Antiphospholipid Syndrome”.
She has recently chaired the ‘EULAR Recommendations for the management of APS in adults’ and the “EULAR recommendations for the cardiovascular management of RMDs including SLE and APS” and she is currently chairing the "Development and Validation of a EULAR disease activity score in Antiphospholipid syndrome" project.
She has participated as clinical investigator in clinical trials on Rheumatoid arthritis, spondyloarthritis, SLE and APS and she was invited speaker in several European and International scientific meetings.
Dr. Tektonidou’s major research interests include the epidemiology, clinical manifestations and management, comorbidities, health-related quality of life, and long-term outcomes of patients with systemic autoimmune diseases, especially APS and SLE. She has over 200 peer-reviewed publications in international journals and book chapters with 15,000 citations and h-index 51 (Google Scholar). She is in the editorial board of 4 international journals, associate editor for the Rheumatology (Oxford) journal, and served as a reviewer for more than 60 international journals.
研究兴趣
论文共 361 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
RHEUMATOLOGYno. SI (2024): SI96-SI106
Rheumatology (Oxford, England)no. SI (2024): SI96-SI106
Rheumatology (Oxford, England)no. SI (2024): SI1-SI3
Antonis Fanouriakis,Myrto Kostopoulou,Jeanette Andersen, Martin Aringer, Laurent Arnaud,Sang-Cheol Bae,John Boletis,Ian N. Bruce,Ricard Cervera,Andrea Doria,Thomas Doerner, Richard A. Furie,
ANNALS OF THE RHEUMATIC DISEASESno. 1 (2024): 15-29
RMD OPENno. 1 (2024)
Christina Tsalapaki,Argyro Lazarini, Evaggelia Argyriou, Vassiliki Dania,Kyriaki Boki,Gerasimos Evangelatos,Alexios Iliopoulos,Maria Pappa,Petros P. Sfikakis,Maria G. Tektonidou,Athanasios Georgountzos, Euripidis Kaltsonoudis,
Rheumatology Internationalno. 4 (2024): 603-610
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn